31 May 2017
Introducing new non-revenue-share AppLovin plugin
Corona Labs provides a wide selection of monetization plugins that fit various developer/business needs, from premium paid options to alternative options which entail no up-front fee. The original AppLovin plugin was designed in the “revenue-share” model where developers can use it for free, but Corona Labs takes a small percentage of the earned ad revenue.
Now, we are pleased to announce that we provide both options for AppLovin, aimed at accommodating different Corona developers and business models:
- The original revenue-share version in which Corona Labs takes a fixed 5% flat rate from earned ad revenue.
- A new AppLovin Paid version of the plugin without any revenue-share component — this version lets you keep 100% of your ad revenue and allows you to manage your account/settings with AppLovin directly.
Like our other premium monetization plugins, AppLovin Paid is available for $199/year in the Corona Marketplace.
If you are a current AppLovin user and you want to switch from the revenue-share version to the paid version, follow this basic process:
- Visit the Corona Marketplace and purchase the AppLovin Paid plugin.
- In your
build.settings
file, change the plugin entry from"plugin.applovin"
to"plugin.applovin.paid"
. - Update any
require()
statements in your code, for example
local applovin = require( "plugin.applovin.paid" )
.
If you haven’t used AppLovin before, please visit our integration documentation and follow the instructions to get up and running.
API updates
In addition to this new plugin, we’ve updated the applovin.load() API for both versions to be more in line with our other monetization plugins. Previously, this API had an obscure method to load interstitial ads versus rewarded video ads. Now, you can call this API with a string like applovin.load("rewardedvideo")
or applovin.load("interstitial")
. Of course, we have maintained backward compatibility with the old syntax, but we recommend updating to the new format.
Sorry, the comment form is closed at this time.